Literature DB >> 32847818

Neurologic complications of COVID-19.

Catherine E Hassett1, Aron Gedansky1, Ibrahim Migdady2, Adarsh Bhimraj3, Ken Uchino4, Sung-Min Cho5.   

Abstract

Patients with COVID-19 have a fairly high risk of neurologic complications, including encephalopathy, stroke, central nervous system infection, seizures, and neuromuscular diseases. Many report losing their senses of smell and taste, and many survivors report lingering neurocognitive impairment. The diagnosis and treatment of these complications does not differ from that in other patients, although sophisticated testing may not be readily available for a patient in intensive care and respiratory isolation. Clinicians should therefore be alert to these complications.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32847818     DOI: 10.3949/ccjm.87a.ccc058

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  8 in total

1.  Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic.

Authors:  Fernando Lozano-Sanchez; Renata Ursu; Anna Luisa Di-Stefano; Francois Ducray; Nadia Younan; Mehdi Touat; Matthieu Groh; Hanane Agguini; Catherine Belin; Luois Garnier; Jean-Yves Delattre; Antoine Carpentier; Ahmed Idbaih
Journal:  Neurooncol Adv       Date:  2021-06-18

2.  Suspected Recurrence of Cranial Neuralgia Following Infection With SARS-CoV-2: A Case Report.

Authors:  Leslie Fuller; Jillian Moehle; Angela Hardin
Journal:  Integr Med (Encinitas)       Date:  2022-05

Review 3.  COVID-19 Pathogenesis and Clinical Manifestations.

Authors:  R Alfonso Hernandez Acosta; Zerelda Esquer Garrigos; Jasmine R Marcelin; Prakhar Vijayvargiya
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905

4.  Body mass index and its association with COVID-19 clinical outcomes: Findings from the Philippine CORONA study.

Authors:  Adrian I Espiritu; Nikolai Gil D Reyes; Carl Froilan D Leochico; Marie Charmaine C Sy; Emilio Q Villanueva Iii; Veeda Michelle M Anlacan; Roland Dominic G Jamora
Journal:  Clin Nutr ESPEN       Date:  2022-03-31

5.  Small-Fiber Neuropathy Possibly Associated with COVID-19.

Authors:  Ahmet Z Burakgazi
Journal:  Case Rep Neurol       Date:  2022-04-22

Review 6.  Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications?

Authors:  Amanda Almeida de Oliveira; Kenia Pedrosa Nunes
Journal:  Vascul Pharmacol       Date:  2021-05-26       Impact factor: 5.773

7.  Neuropsychiatric presentation of Covid-19-related encephalitis: Case report.

Authors:  Marco Orsini; Fábio Henrique de Gobbi Porto; Jacqueline Fernandes do Nascimento
Journal:  Psychiatry Res Commun       Date:  2021-10-28

8.  Treatment of COVID-19-induced refractory status epilepticus by tocilizumab.

Authors:  Esra Kochan Kizilkilic; Rumeysa Unkun; Ugur Uygunoglu; Sakir Delil; Cigdem Ozkara
Journal:  Eur J Neurol       Date:  2022-06-22       Impact factor: 6.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.